Corrigendum to ‘18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment’ (Seminars in Nuclear Medicine (2025) 55(4) (526–537), (S0001299825000571), (10.1053/j.semnuclmed.2025.04.007))

Abstract

The authors regret that there was an error in description for Parkinson's Disease (PD) and Huntington's Disease (HD) in the table 1. So, the authors would like to have table 1 revised as follows: ‘PD: Relatively preserved metabolism in basal ganglia (caudate, putamen); possible mild frontal or occipital hypometabolism. HD: Early bilateral hypometabolism in caudate and putamen; progressive cortical hypometabolism (frontal and parietal) in later stages.’ The authors would like to apologise for any inconvenience caused.